Welcome to our dedicated page for Conduent news (Ticker: CNDT), a resource for investors and traders seeking the latest updates and insights on Conduent stock.
Conduent Incorporated (Nasdaq: CNDT) is a global technology-driven business process solutions and services company whose news flow reflects activity across commercial, government and transportation markets. As a provider of digital business solutions that rely on cloud computing, artificial intelligence, machine learning, automation and advanced analytics, Conduent regularly issues updates on product launches, client implementations, partnerships and financial performance.
News about Conduent often highlights developments in AI and GenAI-powered solutions, including the launch of its AI Experience Center in Florham Park, New Jersey. This center showcases AI- and GenAI-driven offerings for commercial, transportation and government clients, with demonstrations focused on customer experience, document processing, pharma and life sciences, payment fraud mitigation, transportation license plate recognition, human capital solutions and finance, accounting and procurement. Announcements also cover new AI capabilities such as GenAI-powered reportable event detection for pharma and life sciences companies, designed to enhance identification of FDA-reportable events across multiple communication channels.
Transportation-related news features Conduent Transportation’s smart mobility solutions, such as integrated EMV contactless payment systems for public transit operators, Pay-by-Plate tolling systems and the DOT1 next-generation ticket vending machine. These stories describe deployments with transit agencies and toll authorities, including implementations in Italy and contracts with U.S. transportation authorities to support all-electronic tolling and digital ticketing.
Investors and observers will also find coverage of Conduent’s finance and procurement offerings, including enhancements to the FastCap Finance Analytics solution that integrate GenAI-powered contract and spend analytics. In addition, the company issues regular earnings releases and Form 8-K-related announcements detailing quarterly results, credit agreement amendments, board appointments and executive changes.
This news page aggregates such updates, giving readers a single location to review CNDT-related announcements on technology innovation, client wins, transportation projects, government solutions, financial results and corporate governance. Users interested in Conduent’s evolving AI capabilities, smart mobility projects or business process solutions can monitor this feed for ongoing developments.
Conduent (Nasdaq: CNDT) has finalized the sale of its Midas Suite of Solutions to symplr for $340 million, resulting in net proceeds of approximately $270 million for the company. These funds will be utilized for debt repayment and further investments in its business. This transaction aligns with Conduent’s strategy to maximize synergies within its portfolio to boost shareholder and client value. The company remains committed to providing healthcare solutions that enhance member experiences, automate claims, and streamline operations, serving 75% of U.S. insured patients.
Conduent (NASDAQ: CNDT) has secured a five-year agreement to provide health plan management services for the Uniformed Services Family Health Plan (USFHP) at Saint Vincents Catholic Medical Center. This selection follows a competitive bid process and emphasizes scalable solutions in claims processing, member engagement, and fulfillment. USFHP serves military families in the Northeastern U.S. and chose Conduent for its proven expertise and ability to adapt to the evolving healthcare landscape. This partnership aims to enhance operational efficiency and member health outcomes.
Conduent Incorporated (Nasdaq: CNDT) will announce its fourth quarter and full year 2021 financial results on February 16, 2022, post-market close. A conference call will follow at 5:00 p.m. ET to discuss the results. Interested parties can access the call via a live audio webcast or dial-in options. Conduent provides critical services to businesses and governments, improving workflow and efficiency, with significant impacts on operations for clients, including Fortune 100 companies and various government entities.
Conduent (CNDT) has been named a 'Rising Star' in the 2021 ISG Provider Lens™ Healthcare Digital Services Report by ISG, a technology research firm. It received this recognition for its strong portfolio in Payer Digital Transformation Services and Payer Business Process as a Service (BPaaS). The report highlighted Conduent's end-to-end capabilities that enhance member engagement and improve healthcare outcomes. Additionally, the company was recognized as a 'Product Challenger' in Healthcare Interoperability Services & Solutions, showcasing its investment in market presence.
Conduent (Nasdaq: CNDT) has announced a definitive agreement to sell its Midas Suite of Solutions to symplr for $340 million in cash. The Midas suite, generating $72 million in 2020 revenue, supports approximately 2,200 healthcare facilities. This divestiture aligns with Conduent's strategy to streamline operations and enhance shareholder value, with a focus on a smooth transition for clients and team members. The transaction is set to close in the first quarter of 2022, pending regulatory approvals.
Conduent announced a new agreement with the North Dakota Department of Human Services (ND DHS) to enhance the technology for its Medicaid Management Information System (MMIS). This upgrade aims to modernize the full technology stack, improving system reliability, scalability, and security. As a trusted partner, Conduent will help ND DHS better serve over 300,000 North Dakotans. With 50 years of experience, Conduent supports Medicaid systems in various states and has achieved federal MMIS certifications.
Conduent's Maven® has been selected as the new Case and Incident Management System (CIMS) for the UK Health Security Agency (UKHSA), replacing the existing system. This transition aims to bolster public health responses following the COVID-19 pandemic. Maven will initially track acute respiratory infections, including COVID-19, with expansion planned for other diseases by winter 2022. The platform promises advanced configurability, efficient data entry, and streamlined workflows. Conduent, with nearly 40 years in public service, aims to enhance health monitoring and response capabilities.
FAQ
What is the current stock price of Conduent (CNDT)?
What is the market cap of Conduent (CNDT)?
